Clinical and imaging features of interstitial lung disease in cancer patients treated with trastuzum...
Clinical and imaging features of interstitial lung disease in cancer patients treated with trastuzumab deruxtecan
About this item
Full title
Author / Creator
Baba, Tomohisa , Kusumoto, Masahiko , Kato, Terufumi , Kurihara, Yasuyuki , Sasaki, Shinichi , Oikado, Katsunori , Saito, Yoshinobu , Endo, Masahiro , Fujiwara, Yutaka , Kenmotsu, Hirotsugu , Sata, Masafumi , Takano, Toshimi , Kato, Ken , Hirata, Koji , Katagiri, Tomomi , Saito, Hanako and Kuwano, Kazuyoshi
Publisher
Singapore: Springer Nature Singapore
Journal title
Language
English
Formats
Publication information
Publisher
Singapore: Springer Nature Singapore
Subjects
More information
Scope and Contents
Contents
Background
Interstitial lung disease/pneumonitis (ILD/pneumonitis) has been identified as a drug-related adverse event of special interest of trastuzumab deruxtecan (T-DXd), but there were a few reports of T-DXd-related ILD/pneumonitis in clinical practice.
Methods
Between May 25, 2020 (the launch of T-DXd in Japan) and February 24, 2022,...
Alternative Titles
Full title
Clinical and imaging features of interstitial lung disease in cancer patients treated with trastuzumab deruxtecan
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10687185
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10687185
Other Identifiers
ISSN
1341-9625
E-ISSN
1437-7772
DOI
10.1007/s10147-023-02414-x
